The world of cells is surprisingly noisy. Each cell carries unique genetic information, but when we try to measure cellular ...

Analyzing single-cell RNA sequencing (scRNA-seq) data is crucial for understanding complex biological processes and disease development, but identifying individual cell types within these vast ...

The agency held a meeting to gather drugmakers' perspectives as it considers a draft guidance on how previously generated ...

From the moment they're born, newborns—or, specifically, their immune systems—must learn to fight germs without harming their own tissues.

The need to suppress a patient’s immune system after the transplantation of allogeneic cells is associated with wide-ranging side effects. We report the outcomes of transplantation of genetically ...

Announcement of a podium presentation at a prestigious symposium, showcasing innovative research in cell therapy for type 1 diabetes. Presentation features promising clinical data on UP421, a novel ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Adults with type 1 diabetes and recurrent severe ...

Zimislecel is an allogeneic stem cell–derived islet-cell therapy. Data on the safety and efficacy of zimislecel in persons with type 1 diabetes are needed. We conducted a phase 1–2 study of zimislecel ...

The last time I wrote an article on Sana Biotechnology (NASDAQ:SANA) it was with respect to an article entitled "Sana: Major Inflection Point For SC291 In 2025 Targeting Lupus". It is still set to ...

A Vertex Pharmaceuticals cell therapy for type 1 diabetes is enabling patients to produce insulin, eliminating the need for additional insulin therapy in the vast majority of participants in a key ...